Find your path to Caroline
946 people in our graph share verified history with Caroline β schools, employers, funds. One of them is your warm intro.
Nic LowdenunlockedCaroline: together at Credit Suisse (2013β2014)
Γ9Caroline: together at Barclays
Γ2Caroline: together at Credit Suisse
About
Caroline Stout is a Partner at EcoR1 Capital, joining in 2014 and leading several biotechnology investments. She previously served as CIO of Panacea Acquisition Corp I and II and worked as an investment banker at Credit Suisse, and holds an economics degree from Georgetown University.
ContactΒ· self-published, not guessed
Invests in
Biotech
Board director at Affinia Therapeutics
Intro paths
β
In turn, Caroline can intro founders to Affinia Therapeutics's investors below.
Affinia Therapeutics's investors Β· 8
Atlas VentureCambridge Β· $500K β $1M checks Β· since 2025EcoR1 CapitalSan FranciscoEight Roads VenturesMumbai Β· $5M β $30M checksF-Prime CapitalCambridge Β· $3M β $10M checks Β· since 2025GV (Google Ventures)Mountain View Β· $250K β $50M checksNEA SecondaryTimonium Β· since 2025New Enterprise Associates (NEA)Menlo Park Β· $200K β $40M checksTCG CrossoverPalo Alto
Co-founders at Affinia Therapeutics
LV
Luc VandenbergheDirector
AT

Aaron Tward, M.D., Ph.D.Scientific Co-Founder
BR

Botond Roska, M.D., Ph.D.Scientific Co-Founder
LV
Luk Vandenberghe, Ph.D.Scientific Co-Founder and Adviser, and Board Member
Experience
- EcoR1 Capital, LLCPartnercurrent2020 β present
- EcoR1 Capital, LLCPrincipal2014 β 2023San Francisco Bay Area
- Attovia TherapeuticsBoard Observercurrent2025 β present
- Accent Therapeutics, Inc.Board Membercurrent2018 β presentCambridge, MA
- Notch TherapeuticsBoard Member2021 β 2025
- Affinia TherapeuticsBoard Member2021 β 2025
- Neurogene, Inc.Board Member2019 β 2024Greater New York City Area
- Panacea Acquisition Corp. IIChief Investment Officer2021 β 2023
- Affinivax Inc.Board Observer2021 β 2023
- Neogene TherapeuticsBoard Member2020 β 2023
- Panacea Acquisition Corp.Chief Investment Officer2020 β 2021
- Prevail TherapeuticsBoard Member2018 β 2019New York, NY
- Credit SuisseInvestment Banker - Healthcare2013 β 2014Greater New York City Area
- BarclaysIntern2011Wilmington, DE
- Institute for Reproductive Health at Georgetown UniversityResearch Assistant2010 β 2011Bethesda, Maryland
- Pediatrix Medical GroupNewborn Hearing Screener2008 β 2011INOVA Alexandria
Skills & more
AnalysisSpanishFinancial ModelingResearchEconomicsMergers & AcquisitionsMicrosoft OfficeFinancial AnalysisMicrosoft ExcelPowerPointValuationData Analysis
+5 more
Microsoft WordMergersStatisticsDue DiligenceFinanceLanguages Spanish
- Series 79, Limited Representative - Investment Banking β FINRA
From Caroline's professional profile.
Colleagues at EcoR1 Capital
Areesha Saif
Analyst at EcoR1 Capital
Basheer Zada
Principal at EcoR1 Capital
Caroline Cho
Executive Personal Assistant at EcoR1 Capital
Catherine McWilliams
Director of Partner Relations at EcoR1 Capital
Daniel Rodriguez
Counsel at EcoR1 Capital
Geoff Keough
Trader at EcoR1 Capital
Maddie Gehrich
Investor Relations Associate at EcoR1 Capital
Miranda Fornaro
Operations Manager at EcoR1 Capital
Frequently asked questions
- Who is Caroline Stout?
- Caroline Stout is a Partner at EcoR1 Capital, joining in 2014 and leading several biotechnology investments. She previously served as CIO of Panacea Acquisition Corp I and II and worked as an investment banker at Credit Suisse, and holds an economics degree from Georgetown University.
- Where does Caroline Stout work?
- Caroline Stout is Partner at EcoR1 Capital and Board director at Affinia Therapeutics.
- What does Caroline Stout invest in?
- Caroline Stout invests in Biotech.
- Where did Caroline Stout go to school?
- Caroline Stout studied at Georgetown University (BA, Economics (Honors)); The London School of Economics and Political Science (LSE) (Macroeconomics); Duke University (Philosophy).
Same school
Also attended Georgetown University759
Trae StephensPartner at Founders Fund and co-founder of AndurilLuciana LixandruPartner at Sequoia CapitalKatherine BoyleGeneral Partner at Andreessen Horowitz (American Dynamism)Tobi CokerDeal Partner at Felicis VenturesAna AndreescuInvestor at Index VenturesDiana BerishaInvestor at Spark Capital
+ 753 more
Also attended The London School of Economics and Political Science (LSE)1,646
Lee FixelFounder of AdditionPat GradyPartner at Sequoia CapitalNeil MehtaCo-founder & Managing Partner at GreenoaksCyriac ParisotInvestor at Index VenturesSofia DolfeInvestor at Index VenturesJonas VetterleInvestor at Moonfire Ventures
+ 1,640 more
Also attended Duke University953
Marc AndreessenCo-founder & General Partner at Andreessen HorowitzFred EhrsamCo-founder and Senior Advisor at Paradigm; founder of NudgeJeremy LevinePartner at Bessemer Venture PartnersZach PerretCo-founder & CEO of Plaid; co-founder of MischiefJulie YangVice President at InvestcorpAyaan PatelInvestor at Lightbank
+ 947 more
Also attended The Potomac School15
Damien PettyInvestor at Morpheus VenturesAlexis KartalianSenior Coordinator, Portfolio & Community at HalcyonStefanie Thomas-MartinPartner at Zeal Capital PartnersFord WorthyPartner and Senior Advisor at Pappas CapitalStefanie ThomasPartner at Zeal Capital PartnersHunter HeflinSenior Investment Associate at Transpose Platform Management
+ 9 more















































